<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Liang MY</submitter><funding>Hubei Province International Science and Technology Cooperation Project</funding><funding>Fundamental Research Funds for the Central Universities</funding><funding>Program for Chongqing Overseas Returnees</funding><funding>Chongqing Talents of Exceptional Young Talents Project, China</funding><funding>Innovation Platform for Academicians of Hainan Province</funding><funding>National Natural Science Foundation of China</funding><pagination>e2203353</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9475545</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>9(26)</volume><pubmed_abstract>Effective pyroptosis induction is a promising approach to potentiate cancer immunotherapy. However, the actual efficacy of the present pyroptosis inducers can be weakened by successive biological barriers. Here, a cascaded pH-activated supramolecular nanoprodrug (PDNP) with a stepwise size shrinkage property is developed as a pyroptosis inducer to boost antitumor immune response. PDNPs comprise multiple poly(ethylene glycol) (PEG) and doxorubicin (DOX) drug-polymer hybrid repeating blocks conjugated by ultra-pH-sensitive benzoic imine (bzi) and hydrazone (hyd) bonds. The PEG units endow its "stealth" property and ensure sufficient tumor accumulation. A sharp switch in particle size and detachment of PEG shielding can be triggered by the acidic extracellular pH to achieve deep intratumor pe</pubmed_abstract><journal>Advanced science (Weinheim, Baden-Wurttemberg, Germany)</journal><pubmed_title>Stepwise Size Shrinkage Cascade-Activated Supramolecular Prodrug Boosts Antitumor Immunity by Eliciting Pyroptosis.</pubmed_title><pmcid>PMC9475545</pmcid><funding_grant_id>CQYC202005029</funding_grant_id><funding_grant_id>SQ2021PTZ0024</funding_grant_id><funding_grant_id>81874131</funding_grant_id><funding_grant_id>51703187</funding_grant_id><funding_grant_id>82072996</funding_grant_id><funding_grant_id>cstc2021ycjh-bgzxm0061</funding_grant_id><funding_grant_id>2042021kf0216</funding_grant_id><funding_grant_id>32071375</funding_grant_id><funding_grant_id>cx2021017</funding_grant_id><funding_grant_id>2021EHB027</funding_grant_id><pubmed_authors>Sun ZJ</pubmed_authors><pubmed_authors>Qiu W</pubmed_authors><pubmed_authors>Liang MY</pubmed_authors><pubmed_authors>Zhang MJ</pubmed_authors><pubmed_authors>Kang YJ</pubmed_authors><pubmed_authors>Ye MJ</pubmed_authors><pubmed_authors>Xue P</pubmed_authors><pubmed_authors>Xiao Y</pubmed_authors><pubmed_authors>Xu Z</pubmed_authors></additional><is_claimable>false</is_claimable><name>Stepwise Size Shrinkage Cascade-Activated Supramolecular Prodrug Boosts Antitumor Immunity by Eliciting Pyroptosis.</name><description>Effective pyroptosis induction is a promising approach to potentiate cancer immunotherapy. However, the actual efficacy of the present pyroptosis inducers can be weakened by successive biological barriers. Here, a cascaded pH-activated supramolecular nanoprodrug (PDNP) with a stepwise size shrinkage property is developed as a pyroptosis inducer to boost antitumor immune response. PDNPs comprise multiple poly(ethylene glycol) (PEG) and doxorubicin (DOX) drug-polymer hybrid repeating blocks conjugated by ultra-pH-sensitive benzoic imine (bzi) and hydrazone (hyd) bonds. The PEG units endow its "stealth" property and ensure sufficient tumor accumulation. A sharp switch in particle size and detachment of PEG shielding can be triggered by the acidic extracellular pH to achieve deep intratumor pe</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Sep</publication><modification>2025-04-04T20:19:44.072Z</modification><creation>2025-04-04T20:19:44.072Z</creation></dates><accession>S-EPMC9475545</accession><cross_references><pubmed>35869614</pubmed><doi>10.1002/advs.202203353</doi></cross_references></HashMap>